{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:53:25Z","timestamp":1761580405282},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T00:00:00Z","timestamp":1149638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s11307-006-0046-3","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T15:11:29Z","timestamp":1149606689000},"page":"309-314","source":"Crossref","is-referenced-by-count":19,"title":["2-Deoxy-2-[18F]fluoro-d-glucose-Positron Emission Tomography and Positron Emission Tomography\/Computed Tomography Diagnosis of Patients with Recurrent Papillary Thyroid Cancer"],"prefix":"10.1007","volume":"8","author":[{"given":"Andrei","family":"Iagaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinat","family":"Masamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,6,7]]},"reference":[{"issue":"1","key":"46_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal A, Murray T, Ward E, et al. (Jan\u2010Feb 2005) Cancer statistics, 2005. CA Cancer J Clin 55(1):10\u201330","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"46_CR2","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/1097-0142(19941115)74:10<2863::AID-CNCR2820741020>3.0.CO;2-5","volume":"74","author":"AP Polednak","year":"1994","unstructured":"Polednak AP (15 Nov 1994) Trends in cancer incidence in Connecticut, 1935\u20131991. Cancer 74(10):2863\u20132872","journal-title":"Cancer"},{"key":"46_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-4945-1_1","volume-title":"Thyroid Cancer","author":"WJ Mack","year":"1998","unstructured":"Mack WJ, Preston-Martin S (1998) Epidemiology of thyroid cancer. In: Fagin JA (ed) Thyroid Cancer. Boston: Kluwer Academic Publishers, p 1"},{"issue":"11","key":"46_CR4","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1210\/jcem.86.11.8010","volume":"86","author":"T Pal","year":"2001","unstructured":"Pal T, Vogl FD, Chappuis PO, et al. (Nov 2001) Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86(11):5307\u20135312","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"46_CR5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"Mazzaferri EL, Jhiang SM (Nov 1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418\u2013428","journal-title":"Am J Med"},{"issue":"2","key":"46_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000085586","volume":"26","author":"P Siironen","year":"2005","unstructured":"Siironen P, Louhimo J, Nordling S, et al. (3 May 2005) Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumour Biol 26(2):57\u201364","journal-title":"Tumour Biol"},{"issue":"3","key":"46_CR7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.21079","volume":"116","author":"SA Navarro Silvera","year":"2005","unstructured":"Navarro Silvera SA, Miller AB, Rohan TE (1 Sep 2005) Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer 116(3):433\u2013438","journal-title":"Int J Cancer"},{"issue":"7","key":"46_CR8","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1210\/jcem.84.7.5827","volume":"84","author":"W Wang","year":"1999","unstructured":"Wang W, Macapinlac H, Larson SM, et al. (Jul 1999) [18F]-2-Fluoro-2-deoxy-d-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 84(7):2291\u20132302","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"46_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/1097-0347(200102)23:2<94::AID-HED1004>3.0.CO;2-R","volume":"23","author":"JS Yeo","year":"2001","unstructured":"Yeo JS, Chung JK, So Y, et al. (Feb 2001) F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes. Head Neck 23(2):94\u2013103","journal-title":"Head Neck"},{"issue":"5","key":"46_CR10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00006231-200105000-00004","volume":"22","author":"IR McDougall","year":"2001","unstructured":"McDougall IR, Davidson J, Segall GM (May 2001) Positron emission tomography of the thyroid, with an emphasis on thyroid cancer. Nucl Med Commun 22(5):485\u2013492","journal-title":"Nucl Med Commun"},{"issue":"6","key":"46_CR11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00006231-199806000-00006","volume":"19","author":"H Jadvar","year":"1998","unstructured":"Jadvar H, McDougall IR, Segall GM (Jun 1998) Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography. Nucl Med Commun 19(6):547\u2013554","journal-title":"Nucl Med Commun"},{"issue":"5","key":"46_CR12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/108497803770418247","volume":"18","author":"JB Cohen","year":"2003","unstructured":"Cohen JB, Kalinyak JE, McDougall IR (Oct 2003) Modern management of differentiated thyroid cancer. Cancer Biother Radiopharm 18(5):689\u2013705","journal-title":"Cancer Biother Radiopharm"},{"issue":"4","key":"46_CR13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.mlg.0000161337.46892.e0","volume":"115","author":"JR Clark","year":"2005","unstructured":"Clark JR, Lai P, Hall F, Borglund A, Eski S, Freeman JL (Apr 2005) Variables predicting distant metastases in thyroid cancer. Laryngoscope 115(4):661\u2013667","journal-title":"Laryngoscope"},{"issue":"8","key":"46_CR14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/thy.1999.9.797","volume":"9","author":"PS Conti","year":"1999","unstructured":"Conti PS, Durski JM, Bacqai F, Grafton ST, Singer PA (Aug 1999) Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 9(8):797\u2013804","journal-title":"Thyroid"},{"issue":"4","key":"46_CR15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00259-003-1403-y","volume":"31","author":"M Iwata","year":"2004","unstructured":"Iwata M, Kasagi K, Misaki T, et al. (Apr 2004) Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer. Eur J Nucl Med Mol Imaging 31(4):491\u2013498","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"46_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0030-6665(02)00137-8","volume":"36","author":"EG Cohen","year":"2003","unstructured":"Cohen EG, Tuttle RM, Kraus DH (Feb 2003) Postoperative management of differentiated thyroid cancer. Otolaryngol Clin North Am 36(1):129\u2013157","journal-title":"Otolaryngol Clin North Am"},{"issue":"6","key":"46_CR17","first-page":"1010","volume":"41","author":"NS Alnafisi","year":"2000","unstructured":"Alnafisi NS, Driedger AA, Coates G, Moote DJ, Raphael SJ (Jun 2000) FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 41(6):1010\u20131015","journal-title":"J Nucl Med"},{"issue":"3","key":"46_CR18","first-page":"414","volume":"42","author":"T Shiga","year":"2001","unstructured":"Shiga T, Tsukamoto E, Nakada K, et al. (Mar 2001) Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma. J Nucl Med 42(3):414\u2013419","journal-title":"J Nucl Med"},{"issue":"6","key":"46_CR19","first-page":"986","volume":"40","author":"JK Chung","year":"1999","unstructured":"Chung JK, So Y, Lee JS, et al. (Jun 1999) Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 40(6):986\u2013992","journal-title":"J Nucl Med"},{"issue":"12","key":"46_CR20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s002590050493","volume":"26","author":"F Grunwald","year":"1999","unstructured":"Grunwald F, Kalicke T, Feine U, et al. (Dec 1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26(12):1547\u20131552","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"46_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9610(00)00381-0","volume":"179","author":"MA Muros","year":"2000","unstructured":"Muros MA, Llamas-Elvira JM, Ramirez-Navarro A, et al. (Jun 2000) Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels. Am J Surg 179(6):457\u2013461","journal-title":"Am J Surg"},{"issue":"2","key":"46_CR22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.mlg.0000154725.00787.00","volume":"115","author":"Z Nahas","year":"2005","unstructured":"Nahas Z, Goldenberg D, Fakhry C, et al. (Feb 2005) The role of positron emission tomography\/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 115(2):237\u2013243","journal-title":"Laryngoscope"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-006-0046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-006-0046-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-006-0046-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T09:36:17Z","timestamp":1559381777000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-006-0046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,7]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1007\/s11307-006-0046-3","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,7]]}}}